A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma
Simon Chowdhury(Guy's Hospital), J. Infante(Sarah Cannon), Robert D. Hawkins(Cancer Research UK Manchester Institute), Martin H. Voss(Memorial Sloan Kettering Cancer Center), Rodolfo F. Perini(Merck & Co., Inc., Rahway, NJ, USA (United States)), Tobias Arkenau(Sarah Cannon Research Institute), Mark Voskoboynik(Alfred Health), Paola Aimone(Novartis (Switzerland)), Naëije Isabelle(Novartis (Switzerland)), Albert Reising(Novartis (United States)), David F. McDermott(Beth Israel Deaconess Medical Center)
Cited by 37Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis